Advances in Pharmacology, Volume 91, the latest release in this well-received series, presents the latest information in the field, with this update including chapters on Modulation of inflammation and immune response by the stress-activated transcription factor Nrf2, Therapeutic modulation of macrophage phenotype to treat acute and chronic liver diseases, Immodulation by cannabinoids, The use of nanomaterials to target immunity, Next generation in cancer immunotherapy, checkpoint inhibitors, Vaccines as a therapy for food allergy, Role of inflammation/immune system in depression, Therapeutic targeting of tumor-associated macrophages, Mast cells, and more.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
PrefaceCheryl Rockwell and Bryan Copple
1. Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application
Norbert E. Kaminski and Barbara L.F. Kaplan
2. The role of Nrf2 in autoimmunity and infectious disease: Therapeutic possibilities
Robert A. Freeborn and Cheryl E. Rockwell
3. Review of immune checkpoint inhibitors in immuno-oncology
Jennifer B. Jacob, Mark K. Jacob and Prahlad Parajuli
4. Potential therapeutic uses of rexinoids
Ana S. Leal, Lyndsey A. Reich, Jessica A. Moerland, Di Zhang and Karen T. Liby
5. Therapeutic targeting of tumor-associated macrophages
Rikke Kongsgaard Rasmussen and Anders Etzerodt
6. Modulation of macrophage phenotype to treat liver fibrosis-Current approaches and future possibilities
Jenna D. Strickland and Bryan L. Copple
7. Vaccines as therapies for food allergies
Jeffrey J. Landers and Jessica J. O'Konek
8. Neuroimmunology of depression
Erika Sarno, Adam J. Moeser and Alfred J. Robison
9. Nanomaterials to target immunity
Romila Manchanda, Alicia Fernandez-Fernandez , Sesha Lakshmi Arathi Paluri and Bryan Ronain Smith
